Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023929

Enrollment

Registered

2020-12-27

Start date

2017-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C25

Interventions

Group 1: Early recurrence after surgical resection Group 2: Intermediate recurrence after surgical resection Group 3: Late recurrence after surgical resection

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Primary resectable pancreatic ductal adenocarcinoma

Exclusion criteria

Exclusion criteria: Other tumor entities in pt. history

Design outcomes

Primary

Measure	Time frame
Exploratory analysis (retrospektive) for determination of prognostic potential	—

Secondary

Measure	Time frame
Creation of a protein-biomarker panel	—

Countries

Germany

Contacts

Public ContactDietrich Rueß

Allgemein- und Viszeralchirurgie Uniklinik Freiburg

dietrich.ruess@uniklinik-freiburg.de0761-27039100

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026